Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HY209 Gel for Atopic Dermatitis
NCT04530643Phase 2Completed
- Sponsor
- Shaperon
- Start
- Aug 2020
- Primary completion
- Sep 2021
- Modality
- Hydrogel Systems, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of hy209gel in atopic dermatitis (AD), sponsored by Shaperon. Started Aug 2020; status: completed.
02
Drugs
hy209gel
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on NCT04530643.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04530643.